| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner, Member of 10% Owner Group | 10% Owner
1 company
Bindley Capital Partners I, LLC is 10% Owner, Member of 10% Owner Group at GRDN.
Historically, Bindley Capital Partners I, LLC's trades have earned a below-average insider score of 14/100 across 3 rated trades. Over a 12-month horizon, none of those trades were profitable, with an average 12-month return of -78.7%.
The GRDN filings lean toward selling, a net 7,731,036 shares.
Bindley Capital Partners I, LLC has 5 Form 4 filings on record from May 2025 to September 2026, all as 10% Owner, Member of 10% Owner Group at Guardian Pharmacy Services (GRDN), 2025–2026.
The 6 reported transactions were 3 option exercises and 3 open-market sales.
Counted by filing, the open-market trades come to no purchases and 2 sales worth about $189.9M.
The largest open-market sale was 3,570,677 shares of GRDN at an average $29.68 on March 20, 2026, about $106.0M.
Neither of the two sales since April 2023 was marked as made under a Rule 10b5-1 trading plan.